 regulator rule pain drug food drug regulators decide recommend sale painkillers linked high risk heart attack stroke food drug administration advisory panel verdict hearing evidence days painkillers called inhibitors sold brand names withdrawn shops consider selling gets approval asked decide benefits patients justify increased risks putting shelves likely boost profits make easier legal battles people claim injured drug analysts voluntarily stopped sales caused firm earnings slide earlier shares tumbled news company set aside millions dollars cover cost litigation alarm bells rung research note called approve showed risk heart attack stroke doubled patients taking drug months inhibitors developed drug companies including cause users fewer stomach problems painkillers selling products investigations suggested harmful heart announcement possible reintroduction caught analysts surprise head research peter withdrew based information available time knowing alternative therapies went things changed light new reports given new information clear cardiovascular risk observed approve makes unique class similar drugs marketed explained graham office drug safety told advisory panel really appear need inhibitors according calculations presented senate graham linked 56,000 deaths facing stem criticism handling case create independent body oversee safety drugs market place regulators ruled patients heart disease stroke inhibitors medicines agency doctors cautious giving drugs patients risk factors heart disease